Search results
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
WHAS TV11 Louisville· 5 days agoThe pharmaceutical company said fake versions of its drugs frequently advertised or sold online are...
Eli Lilly Files More Lawsuits at Sellers of Counterfeit Mounjaro, Zepbound
The Wall Street Journal· 5 days agoThe pharmaceutical company said it filed legal actions against med-spas, wellness centers and other...
Growing use of Ozempic, other weight-loss drugs boosts clothing sales, cuts food spending
Newsday· 5 days agoPenny Lane Boutique has seen a surge in customers buying smaller-size wardrobes in the past six...
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
Barrons.com· 20 hours agoStrong results from Eli Lilly’s obesity medicine in a sleep apnea trial could upset the sleep apnea...
Focus: Food companies with Ozempic-friendly snacks and meals wade carefully into weight-loss waters
Reuters· 5 days ago, opens new tab new food brand for people taking weight-loss drugs like Wegovy will note that the...
Eli Lilly wins settlement against Charleston med-spa over counterfeit weight loss drug
The Post and Courier· 4 days agoA federal judge said in a May 15 order that the firm falsely advertised its compounded drugs...
Tirzepatide Significantly Reduces Sleep Disruptions
Medscape· 3 days agoThe diabetes and weight loss drug tirzepatide (Mounjaro for type 2 diabetes; Zepbound for obesity) was so effective at reducing sleep ...
Eli Lilly warns about dangers of fake and counterfeit Mounjaro, Zepbound
ABC 7 Chicago· 5 days agoPharmaceutical company Eli Lilly issued a warning in an open letter on Thursday about the dangers of...
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line - Novo Nordisk (NYSE:NVO), Eli...
Benzinga· 4 days agoLast month, Nestlé SA NSRGF NSRGY unveiled Vital Pursuit, a new line of foods designed to complement...
Fake Wegovy and Ozempic warnings: What to know
FOX 10 Phoenix· 5 days agoThe diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, joined LiveNow to discuss how...